Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
S-8 Feb 3, 2023 S-8
4 Feb 3, 2023 FORM 4
10-Q Feb 3, 2023 10-Q
8-K Feb 3, 2023 8-K
4 Jan 27, 2023 FORM 4
4 Jan 13, 2023 FORM 4
4 Jan 13, 2023 FORM 4
4 Jan 13, 2023 FORM 4
4 Jan 13, 2023 FORM 4
8-K Jan 9, 2023 8-K
8-K Dec 8, 2022 8-K
SC 13G/A Dec 5, 2022 SC 13G/A
SC 13G/A Dec 2, 2022 SC 13G/A
10-Q Nov 4, 2022 10-Q
8-K Nov 4, 2022 8-K
4 Oct 25, 2022 FORM 4
4 Oct 17, 2022 FORM 4
4 Oct 17, 2022 FORM 4
4 Oct 13, 2022 FORM 4
4 Oct 7, 2022
424B5 Oct 5, 2022 424B5
8-K Oct 4, 2022 8-K
4 Oct 4, 2022 FORM 4
4 Sep 29, 2022 FORM 4
4 Sep 29, 2022 FORM 4
← Newer Page 14 of 26 · 643 filings Older →